个人中心 - 老虎社区

w8w8

hope the new year brings joy

IP属地：未知

帖子 · 369帖子 · 369
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- w8w8w8w8
  ·2021-11-26
  Steamed
  Merck says COVID-19 pill cuts hospitalization, death risk by 30%
  Nov 26 (Reuters) - Merck & Co Inc said on Friday its experimental COVID-19 pill reduced the risk of
  Merck says COVID-19 pill cuts hospitalization, death risk by 30%
  767 评论
  2
  分享
  举报
- w8w8w8w8
  ·2021-11-26
  Steamed
  BioNTech says expect more data on new variant in 2 weeks
  FRANKFURT, Nov 26 (Reuters) - BioNTech , the inventor of the western world's most widely used COVID-
  BioNTech says expect more data on new variant in 2 weeks
  955 评论
  1
  分享
  举报
- w8w8w8w8
  ·2021-11-26
  Sreamed
  Cardiovascular Systems Recalls Wirion Embolic Protection System
  Cardiovascular Systems Inc has commenced a voluntary recall of its WIRION Embolic Protection Systems
  Cardiovascular Systems Recalls Wirion Embolic Protection System
  796 1
  1
  分享
  举报
- w8w8w8w8
  ·2021-09-21
  $AGC Inc.(ASGLY)$ssteamed
  404 评论
  1
  分享
  举报
- w8w8w8w8
  ·2021-09-20
  Staff
  Investors in Procter & Gamble have made a favorable return of 82% over the past three years
  One simple way to benefit from the stock market is to buy an index fund. But if you pick the right i
  Investors in Procter & Gamble have made a favorable return of 82% over the past three years
  583 评论
  1
  分享
  举报
- w8w8w8w8
  ·2021-09-20
  Steamed
  Wall Street closes rollercoaster week sharply lower
  NEW YORK - US stocks ended sharply lower in a broad sell-off on Friday , ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and possible shifts in the US Federal Reserve's timeline for tapering asset purchases.All three major US stock indexes lost ground, with the Nasdaq Composite Index's weighed down as rising US Treasury yields pressured market-leading growth stocks.They also posted weekly losses, with the S&P index suffering its biggest tw
  Wall Street closes rollercoaster week sharply lower
  230 评论
  点赞
  分享
  举报
- w8w8w8w8
  ·2021-09-20
  $AGC Inc.(ASGLY)$ssteames
  246 评论
  点赞
  分享
  举报
- w8w8w8w8
  ·2021-09-19
  Steamed
  Better Buy: AMD vs. Micron Technology
  You may be surprised at the winner of this comparison.
  Better Buy: AMD vs. Micron Technology
  409 评论
  1
  分享
  举报
- w8w8w8w8
  ·2021-09-19
  $AGC Inc.(ASGLY)$ssteamed
  281 评论
  点赞
  分享
  举报
- w8w8w8w8
  ·2021-09-16
  Steamed
  非常抱歉，此主贴已删除
  228 评论
  1
  分享
  举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3575859183800572","uuid":"3575859183800572","gmtCreate":1612765950053,"gmtModify":1613901984658,"name":"w8w8","pinyin":"w8w8","introduction":"","introductionEn":null,"signature":"hope the new year brings joy","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":60,"headSize":22,"tweetSize":369,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":877218169,"gmtCreate":1637935116522,"gmtModify":1637935116811,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"Steamed","listText":"Steamed","text":"Steamed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877218169","repostId":"2186106673","repostType":4,"repost":{"id":"2186106673","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637930934,"share":"https://www.laohu8.com/m/news/2186106673?lang=&edition=full","pubTime":"2021-11-26 20:48","market":"us","language":"en","title":"Merck says COVID-19 pill cuts hospitalization, death risk by 30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2186106673","media":"Reuters","summary":"Nov 26 (Reuters) - Merck & Co Inc said on Friday its experimental COVID-19 pill reduced the risk of ","content":"<p>Nov 26 (Reuters) - Merck &amp; Co Inc said on Friday its experimental COVID-19 pill reduced the risk of hospitalization and death by 30% in a study, according to data from all the patients enrolled in a late-stage study.</p>\n<p>The company said the data on the drug molnupiravir, developed with Ridgeback Biotherapeutics, had been submitted to the U.S. Food and Drug Administration ahead of a meeting of its expert advisers on Tuesday.</p>\n<p>A planned interim analysis of the data last month showed that 7.3% of those given molnupiravir twice a day for five days were hospitalized and none had died by 29 days after the treatment. That compared with a hospitalization rate of 14.1% for placebo patients.</p>\n<p>In the updated data, 6.8% of those given molnupiravir were hospitalized and one person died, while the other placebo group had a hospitalization rate of 9.7%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck says COVID-19 pill cuts hospitalization, death risk by 30%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck says COVID-19 pill cuts hospitalization, death risk by 30%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-26 20:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nov 26 (Reuters) - Merck &amp; Co Inc said on Friday its experimental COVID-19 pill reduced the risk of hospitalization and death by 30% in a study, according to data from all the patients enrolled in a late-stage study.</p>\n<p>The company said the data on the drug molnupiravir, developed with Ridgeback Biotherapeutics, had been submitted to the U.S. Food and Drug Administration ahead of a meeting of its expert advisers on Tuesday.</p>\n<p>A planned interim analysis of the data last month showed that 7.3% of those given molnupiravir twice a day for five days were hospitalized and none had died by 29 days after the treatment. That compared with a hospitalization rate of 14.1% for placebo patients.</p>\n<p>In the updated data, 6.8% of those given molnupiravir were hospitalized and one person died, while the other placebo group had a hospitalization rate of 9.7%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","MRK":"默沙东","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓","BK4516":"特朗普概念","BK4550":"红杉资本持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186106673","content_text":"Nov 26 (Reuters) - Merck & Co Inc said on Friday its experimental COVID-19 pill reduced the risk of hospitalization and death by 30% in a study, according to data from all the patients enrolled in a late-stage study.\nThe company said the data on the drug molnupiravir, developed with Ridgeback Biotherapeutics, had been submitted to the U.S. Food and Drug Administration ahead of a meeting of its expert advisers on Tuesday.\nA planned interim analysis of the data last month showed that 7.3% of those given molnupiravir twice a day for five days were hospitalized and none had died by 29 days after the treatment. That compared with a hospitalization rate of 14.1% for placebo patients.\nIn the updated data, 6.8% of those given molnupiravir were hospitalized and one person died, while the other placebo group had a hospitalization rate of 9.7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":767,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877218338,"gmtCreate":1637935105545,"gmtModify":1637935105843,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"Steamed","listText":"Steamed","text":"Steamed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877218338","repostId":"2186488363","repostType":4,"repost":{"id":"2186488363","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637933108,"share":"https://www.laohu8.com/m/news/2186488363?lang=&edition=full","pubTime":"2021-11-26 21:25","market":"us","language":"en","title":"BioNTech says expect more data on new variant in 2 weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2186488363","media":"Reuters","summary":"FRANKFURT, Nov 26 (Reuters) - BioNTech , the inventor of the western world's most widely used COVID-","content":"<p>FRANKFURT, Nov 26 (Reuters) - BioNTech , the inventor of the western world's most widely used COVID-19 vaccine, said it expects more laboratory data on a new worrying coronavirus variant detected in South Africa within two weeks to help determine whether its shot would have to be reworked.</p>\n<p>\"We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529,\" the company, which is in a vaccine alliance with Pfizer , said in a statement when asked to comment.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" it added.</p>\n<p>Global authorities reacted with alarm on Friday to the new variant, with the EU and Britain among those tightening border controls as scientists sought to find out if the mutation was vaccine-resistant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech says expect more data on new variant in 2 weeks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech says expect more data on new variant in 2 weeks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-26 21:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>FRANKFURT, Nov 26 (Reuters) - BioNTech , the inventor of the western world's most widely used COVID-19 vaccine, said it expects more laboratory data on a new worrying coronavirus variant detected in South Africa within two weeks to help determine whether its shot would have to be reworked.</p>\n<p>\"We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529,\" the company, which is in a vaccine alliance with Pfizer , said in a statement when asked to comment.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" it added.</p>\n<p>Global authorities reacted with alarm on Friday to the new variant, with the EU and Britain among those tightening border controls as scientists sought to find out if the mutation was vaccine-resistant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186488363","content_text":"FRANKFURT, Nov 26 (Reuters) - BioNTech , the inventor of the western world's most widely used COVID-19 vaccine, said it expects more laboratory data on a new worrying coronavirus variant detected in South Africa within two weeks to help determine whether its shot would have to be reworked.\n\"We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529,\" the company, which is in a vaccine alliance with Pfizer , said in a statement when asked to comment.\n\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" it added.\nGlobal authorities reacted with alarm on Friday to the new variant, with the EU and Britain among those tightening border controls as scientists sought to find out if the mutation was vaccine-resistant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":955,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877218946,"gmtCreate":1637935093719,"gmtModify":1637935094035,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"Sreamed","listText":"Sreamed","text":"Sreamed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877218946","repostId":"1182136836","repostType":4,"repost":{"id":"1182136836","kind":"news","pubTimestamp":1637934244,"share":"https://www.laohu8.com/m/news/1182136836?lang=&edition=full","pubTime":"2021-11-26 21:44","market":"us","language":"en","title":"Cardiovascular Systems Recalls Wirion Embolic Protection System","url":"https://stock-news.laohu8.com/highlight/detail?id=1182136836","media":"Benzinga","summary":"Cardiovascular Systems Inc has commenced a voluntary recall of its WIRION Embolic Protection Systems","content":"<p><b>Cardiovascular Systems Inc</b>&nbsp;has&nbsp;commenced a voluntary recall&nbsp;of its WIRION Embolic Protection Systems (WIRION).</p>\n<ul>\n <li>The unused WRN-D6 models of the WIRION device are being recalled due to receiving complaints regarding filter breakage at the time of retrieval.</li>\n <li>The Company stated that the filter breakage might cause device embolism as well as additional intervention.</li>\n <li>All affected healthcare facilities were informed to stop using and return the unused WIRION devices to the Company.</li>\n <li>CSI has also notified the FDA regarding the voluntary recall.</li>\n <li>The Company has received nine filter breakage complaints so far and plans to recall all the devices currently in customer inventory.</li>\n <li>Between 22 March and 15 November, approximately 697 devices were distributed in the US.</li>\n <li>WIRION is a rapid exchange, pre-loaded filter used as an embolic protection system for removing embolic material (thrombus/debris) while performing atherectomy in calcified lesions of the lower extremities.</li>\n <li>In March, CSI&nbsp;acquired a portfolio of peripheral support catheters&nbsp;from&nbsp;<b>WavePoint Medical</b>.</li>\n <li>These catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to aid in lesion crossing and for guidewire exchanges.</li>\n <li>CSI expects to introduce the acquired catheters as its new ViperCross line in the first half of its fiscal year, ending on 30 June 2022.</li>\n <li><b>Price Action:</b>&nbsp;CSII shares closed at $23.72 on Wednesday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cardiovascular Systems Recalls Wirion Embolic Protection System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCardiovascular Systems Recalls Wirion Embolic Protection System\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 21:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24302601/cardiovascular-systems-recalls-wirion-embolic-protection-system><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cardiovascular Systems Inc has commenced a voluntary recall of its WIRION Embolic Protection Systems (WIRION).\n\nThe unused WRN-D6 models of the WIRION device are being recalled due to receiving ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24302601/cardiovascular-systems-recalls-wirion-embolic-protection-system\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CSII":"Cardiovascular Systems"},"source_url":"https://www.benzinga.com/news/21/11/24302601/cardiovascular-systems-recalls-wirion-embolic-protection-system","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182136836","content_text":"Cardiovascular Systems Inc has commenced a voluntary recall of its WIRION Embolic Protection Systems (WIRION).\n\nThe unused WRN-D6 models of the WIRION device are being recalled due to receiving complaints regarding filter breakage at the time of retrieval.\nThe Company stated that the filter breakage might cause device embolism as well as additional intervention.\nAll affected healthcare facilities were informed to stop using and return the unused WIRION devices to the Company.\nCSI has also notified the FDA regarding the voluntary recall.\nThe Company has received nine filter breakage complaints so far and plans to recall all the devices currently in customer inventory.\nBetween 22 March and 15 November, approximately 697 devices were distributed in the US.\nWIRION is a rapid exchange, pre-loaded filter used as an embolic protection system for removing embolic material (thrombus/debris) while performing atherectomy in calcified lesions of the lower extremities.\nIn March, CSI acquired a portfolio of peripheral support catheters from WavePoint Medical.\nThese catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to aid in lesion crossing and for guidewire exchanges.\nCSI expects to introduce the acquired catheters as its new ViperCross line in the first half of its fiscal year, ending on 30 June 2022.\nPrice Action: CSII shares closed at $23.72 on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":796,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":869026803,"gmtCreate":1632230481802,"gmtModify":1632801930727,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASGLY\">$AGC Inc.(ASGLY)$</a>ssteamed","listText":"<a href=\"https://laohu8.com/S/ASGLY\">$AGC Inc.(ASGLY)$</a>ssteamed","text":"$AGC Inc.(ASGLY)$ssteamed","images":[{"img":"https://static.tigerbbs.com/5bd17eae2e22744ebad31e79a0f97a74","width":"1080","height":"3826"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/869026803","isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":860895277,"gmtCreate":1632150264799,"gmtModify":1632802489682,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"Staff","listText":"Staff","text":"Staff","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860895277","repostId":"2168168393","repostType":4,"repost":{"id":"2168168393","kind":"news","pubTimestamp":1632148689,"share":"https://www.laohu8.com/m/news/2168168393?lang=&edition=full","pubTime":"2021-09-20 22:38","market":"us","language":"en","title":"Investors in Procter & Gamble have made a favorable return of 82% over the past three years","url":"https://stock-news.laohu8.com/highlight/detail?id=2168168393","media":"Simply Wall St.","summary":"One simple way to benefit from the stock market is to buy an index fund. But if you pick the right i","content":"<p>One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks, you could make more than that. For example, the <b>The Procter &amp; Gamble Company</b> (NYSE:PG) share price is up 68% in the last three years, clearly besting the market return of around 50% (not including dividends). However, more recent returns haven't been as impressive as that, with the stock returning just 7.6% in the last year , including dividends .</p>\n<p>So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.</p>\n<p>To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).</p>\n<p>During three years of share price growth, Procter &amp; Gamble achieved compound earnings per share growth of 15% per year. This EPS growth is lower than the 19% average annual increase in the share price. This suggests that, as the business progressed over the last few years, it gained the confidence of market participants. It's not unusual to see the market 're-rate' a stock, after a few years of growth.</p>\n<p>The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).</p>\n<p><img src=\"https://s1.yimg.com/uu/api/res/1.2/_cSIoEfLhS1hCmPnYyrWbA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/simply_wall_st__316/900da8a28132d767626669b0db0147fa\" tg-width=\"821\" tg-height=\"520\" referrerpolicy=\"no-referrer\">NYSE:PG Earnings Per Share Growth September 20th 2021</p>\n<p>We know that Procter &amp; Gamble has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Procter &amp; Gamble will grow revenue in the future.</p>\n<h3>What About Dividends?</h3>\n<p>It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Procter &amp; Gamble, it has a TSR of 82% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence!</p>\n<h3>A Different Perspective</h3>\n<p>Procter &amp; Gamble shareholders are up 7.6% for the year (even including dividends). Unfortunately this falls short of the market return. If we look back over five years, the returns are even better, coming in at 14% per year for five years. It's quite possible the business continues to execute with prowess, even as the share price gains are slowing. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted <b> 2 warning signs for Procter &amp; Gamble</b> you should be aware of.</p>\n<p>For those who like to find <b>winning investments</b> this <b>free</b> list of growing companies with recent insider purchasing, could be just the ticket.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investors in Procter & Gamble have made a favorable return of 82% over the past three years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvestors in Procter & Gamble have made a favorable return of 82% over the past three years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-20 22:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/investors-procter-gamble-nyse-pg-143809995.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks, you could make more than that. For example, the The Procter & Gamble Company (NYSE...</p>\n\n<a href=\"https://finance.yahoo.com/news/investors-procter-gamble-nyse-pg-143809995.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ISBC":"投资者银行","PG":"宝洁"},"source_url":"https://finance.yahoo.com/news/investors-procter-gamble-nyse-pg-143809995.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2168168393","content_text":"One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks, you could make more than that. For example, the The Procter & Gamble Company (NYSE:PG) share price is up 68% in the last three years, clearly besting the market return of around 50% (not including dividends). However, more recent returns haven't been as impressive as that, with the stock returning just 7.6% in the last year , including dividends .\nSo let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.\nTo quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).\nDuring three years of share price growth, Procter & Gamble achieved compound earnings per share growth of 15% per year. This EPS growth is lower than the 19% average annual increase in the share price. This suggests that, as the business progressed over the last few years, it gained the confidence of market participants. It's not unusual to see the market 're-rate' a stock, after a few years of growth.\nThe company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).\nNYSE:PG Earnings Per Share Growth September 20th 2021\nWe know that Procter & Gamble has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Procter & Gamble will grow revenue in the future.\nWhat About Dividends?\nIt is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Procter & Gamble, it has a TSR of 82% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence!\nA Different Perspective\nProcter & Gamble shareholders are up 7.6% for the year (even including dividends). Unfortunately this falls short of the market return. If we look back over five years, the returns are even better, coming in at 14% per year for five years. It's quite possible the business continues to execute with prowess, even as the share price gains are slowing. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted  2 warning signs for Procter & Gamble you should be aware of.\nFor those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":583,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860895147,"gmtCreate":1632150236489,"gmtModify":1632802489924,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"Steamed","listText":"Steamed","text":"Steamed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860895147","repostId":"2168716185","repostType":2,"repost":{"id":"2168716185","kind":"news","pubTimestamp":1631916051,"share":"https://www.laohu8.com/m/news/2168716185?lang=&edition=full","pubTime":"2021-09-18 06:00","market":"us","language":"en","title":"Wall Street closes rollercoaster week sharply lower","url":"https://stock-news.laohu8.com/highlight/detail?id=2168716185","media":"The Straits Times","summary":"NEW YORK  - US stocks ended sharply lower in a broad sell-off on Friday , ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and possible shifts in the US Federal Reserve's timeline for tapering asset purchases.All three major US stock indexes lost ground, with the Nasdaq Composite Index's weighed down as rising US Treasury yields pressured market-leading growth stocks.They also posted weekly losses, with the S&P index suffering its biggest tw","content":"<div>\n<p>NEW YORK (REUTERS) - US stocks ended sharply lower in a broad sell-off on Friday (Sept 17), ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes rollercoaster week sharply lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes rollercoaster week sharply lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-18 06:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (REUTERS) - US stocks ended sharply lower in a broad sell-off on Friday (Sept 17), ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SH":"标普500反向ETF","SSO":"两倍做多标普500ETF","UPRO":"三倍做多标普500ETF",".SPX":"S&P 500 Index","SDS":"两倍做空标普500ETF","IVV":"标普500指数ETF","OEX":"标普100","SPXU":"三倍做空标普500ETF","OEF":"标普100指数ETF-iShares"},"source_url":"http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168716185","content_text":"NEW YORK (REUTERS) - US stocks ended sharply lower in a broad sell-off on Friday (Sept 17), ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and possible shifts in the US Federal Reserve's timeline for tapering asset purchases.\nAll three major US stock indexes lost ground, with the Nasdaq Composite Index's weighed down as rising US Treasury yields pressured market-leading growth stocks.\nThey also posted weekly losses, with the S&P index suffering its biggest two-week drop since February.\n\"The market is struggling with prospects for tighter fiscal policy due to tax increases, and tighter monetary policy due to Fed tapering,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York.\n\"Equity markets are also a little softer due to today's weak Consumer Sentiment data,\" Carter added. \"It's triggering concerns that the Delta variant could slow economic growth.\"\nA potential hike in corporate taxes could eat into earnings also weigh on markets, with leading Democrats seeking to raise the top tax rate on corporations to 26.5 per cent from the current 21 per cent.\nWhile consumer sentiment steadied this month it remains depressed, according to a University of Michigan report, as Americans postpone purchases while inflation remains high.\nInflation is likely to be a major issue next week, when the Federal Open Markets Committee holds its two-day monetary policy meeting. Market participants will be watching closely for changes in nuance which could signal a shift in the Fed's tapering timeline.\n\"It has been a week of mixed economic data and we are focused clearly on what will come out of the Fed meeting next week,\" said Bill Northey, senior investment director at US Bank Wealth Management in Helena, Montana.\nThe Dow Jones Industrial Average fell 166.44 points, or 0.48 per cent, to 34,584.88; the S&P 500 lost 40.76 points, or 0.91 per cent, at 4,432.99; and the Nasdaq Composite dropped 137.96 points, or 0.91 per cent, to 15,043.97.\nThe S&P 500 ended below its 50-day moving average, which in recent history has proven a rather sturdy support level.\nOf the 11 major sectors in the S&P 500, all but healthcare ended in the red, with materials and utilities suffering the biggest percentage drops.\nWall Street ends rollercoaster week sharply lower\nCovid-19 vaccine manufacturers Pfizer and Moderna dropped 1.3 per cent and 2.4 per cent, respectively, as US health officials moved the debate over booster doses to a panel of independent experts.\nUS Steel Corp shed 8 per cent after it unveiled a US$3 billion (S$4 billion) mini-mill investment plan.\nVolume and volatility spiked toward the end of the session due to \"triple witching,\" which is the quarterly, simultaneous expiration of stock options, stock index futures, and stock index options contracts.\nVolume on US exchanges was 15.51 billion shares, compared with the 9.70 billion average over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.97-to-1 ratio; on Nasdaq, a 1.00-to-1 ratio favoured advancers.\nThe S&P 500 posted seven new 52-week highs and two new lows; the Nasdaq Composite recorded 67 new highs and 82 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860896571,"gmtCreate":1632150139493,"gmtModify":1632802491374,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASGLY\">$AGC Inc.(ASGLY)$</a>ssteames","listText":"<a href=\"https://laohu8.com/S/ASGLY\">$AGC Inc.(ASGLY)$</a>ssteames","text":"$AGC Inc.(ASGLY)$ssteames","images":[{"img":"https://static.tigerbbs.com/2880a2ee8ee3404ea25be5c294c5cea6","width":"1080","height":"3826"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860896571","isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":887271966,"gmtCreate":1632055638955,"gmtModify":1632803107615,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"Steamed","listText":"Steamed","text":"Steamed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887271966","repostId":"2168752097","repostType":4,"repost":{"id":"2168752097","kind":"highlight","pubTimestamp":1631889000,"share":"https://www.laohu8.com/m/news/2168752097?lang=&edition=full","pubTime":"2021-09-17 22:30","market":"us","language":"en","title":"Better Buy: AMD vs. Micron Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2168752097","media":"Motley Fool","summary":"You may be surprised at the winner of this comparison.","content":"<p>Five months ago, stock for <b>Advanced Micro Devices</b> (NASDAQ:<a href=\"https://laohu8.com/S/AMD\">AMD</a>) and <b>Micron Technology</b> (NASDAQ:MU) were following different trajectories when it came to their prices. Micron started the year on a positive note thanks to the terrific demand for memory chips, while AMD was struggling in the wake of the sell-off in tech stocks and market share gains clocked by <b>Intel</b>.</p>\n<p>But things have changed remarkably for the performance of the two stocks since then.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/11d2f5d2fc8e48d2b56743df18cfbde4\" tg-width=\"720\" tg-height=\"449\" width=\"100%\" height=\"auto\"><span>AMD data by YCharts</span></p>\n<p>AMD has regained its mojo thanks to consistently strong quarterly results and a solid outlook for 2021. Micron, on the other hand, has lost investor confidence due to concerns about the health of the memory market. That's not surprising -- investor sentiment in Micron stock is dictated by the booms and busts in the cyclical memory market, as I pointed out in April, while AMD is sitting on secular tailwinds that could ensure long-term growth.</p>\n<p>As a result, AMD looked like the better buy in April, and the stock's performance since then justifies that call. But with Micron now trading at a dirt-cheap valuation and the prospects of the memory market looking up, is it now a better bet over AMD? Let's find out if my investing advice has changed.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7d37411519d470ff3c53a15776d3013c\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>The case for Advanced Micro Devices</h2>\n<p>There are three reasons why AMD remains a stock worth buying even after its impressive rally over the past few months.</p>\n<p>First, the chipmaker continues to hurt Intel in the x86 CPU (central processing unit) market. Mercury Research estimates that AMD's CPU market share reached a 14-year high in the second quarter of 2021, hitting 22.5%, an increase of 4.2 percentage points over the year-ago quarter. AMD has doubled&nbsp;its CPU market share at Intel's expense in the past two to three years, and it seems on its way to further improve its positioning thanks to an advanced manufacturing process.</p>\n<p>A stronger market share in the CPU space is going to be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of AMD's biggest catalysts, as its computing and graphics business is still quite small compared to Intel's. Similarly, AMD's gains in the server processor market could add billions of dollars to its revenue in the future.</p>\n<p>Second, AMD is on track to take advantage of growing graphics card demand. Jon Peddie Research estimates&nbsp;that it holds 17% of the discrete graphics processing unit (GPU) market, with <b>Nvidia</b> controlling the rest. There is no doubt that Nvidia is the dominant graphics card provider, but AMD investors shouldn't forget that discrete GPU sales are expected&nbsp;to jump from $29 billion in 2020 to $44 billion in 2023.</p>\n<p>If AMD continues to hold even a 20% share of the discrete GPU market in the future, it could substantially increase its revenue.</p>\n<p>Third, AMD's dominant position in video gaming consoles adds yet another potent catalyst to the company's portfolio. AMD's enterprise, embedded, and semi-custom (EESC) business is winning big from the <b>Sony</b> PlayStation 5 and the latest <b>Microsoft</b> Xbox consoles, which use its semi-custom chips.</p>\n<p>The EESC business is built for long-term growth as well, as the new console generation is still in its early phases. According to third-party estimates, the PS5 could clock&nbsp;67 million units in annual sales by 2024, which would be a huge jump over the 4.5 million units&nbsp;sold last year. Throw in the fact that AMD has won the contract to supply chips for an upcoming handheld gaming console that could turn out to be a big success, and it's easy to see why AMD's EESC business will keep firing on all cylinders.</p>\n<p>Given all these tailwinds, it is not surprising to see that AMD expects revenue to jump&nbsp;60% in 2021. Even better, analysts believe that the company's robust growth is here to stay for the long run, as AMD's earnings are expected to grow at an annual pace of over 32% for the next five years. As such, AMD looks all set to sustain its recent rally thanks to multiple growth drivers.</p>\n<h2>The case for Micron</h2>\n<p>Micron shares have tumbled over the past few months despite the absence of any visible signs of weakness in the company's business. The company's third-quarter revenue increased 36% year over year to $7.42 billion, while adjusted earnings per share jumped to $1.88 per share from $0.82 per share in the year-ago quarter. The strong memory pricing environment sent Micron's operating income to 31.9% during the quarter from 18% in the year-ago period.</p>\n<p>What's more, Micron's guidance suggests that it isn't going to run out of steam. The company expects $8.2 billion in fiscal fourth-quarter revenue and earnings of $2.30 per share, which would translate into 35% year-over-year revenue growth and a sharp jump from the prior-year period's earnings of $1.08 per share. It is surprising to see Micron shares taking a beating despite such outstanding numbers. But investors' trepidation seems justified, as drops in memory prices have historically been bad news for the company.</p>\n<p>However, the massive end-market demand for memory chips suggests that memory prices may continue to hold up. For instance, memory industry market research provider TrendForce estimates&nbsp;that robust demand from data center servers could push up server DRAM (dynamic random access memory) prices by 5% to 10% in the current quarter.</p>\n<p>More importantly, the server market is set up for long-term growth. Mordor Intelligence estimates&nbsp;a 12% annual increase in enterprise server spending through 2026 on account of the deployment of hyperscale data centers and increased server storage demand. A similar scenario is unfolding in the mobile DRAM market, where the deployment of 5G smartphones has led to a sharp increase in demand.</p>\n<p>Counterpoint Research estimates that mobile DRAM revenue increased 30% year over year in the first quarter of 2021 thanks to an increase in the average DRAM capacity per smartphone. As 5G smartphones are being equipped with more DRAM and are still in their early phases of growth, Micron should continue witnessing healthy demand from this market.</p>\n<p>With mobile and servers accounting for nearly three-fourths of the overall DRAM market, investors' fear of a drop-off in memory demand could remain unjustified. Finally, the secular catalysts Micron stands to gain from could result in a massive acceleration in its revenue and earnings over the coming years, according to analysts' estimates.</p>\n<p>In fact, analysts expect&nbsp;Micron's earnings to clock a compound annual growth rate of 58% for the next five years, which is substantially higher than what's expected from AMD.</p>\n<h2>The verdict</h2>\n<p>By now it should be evident that both Micron and AMD can continue to sustain their impressive growth in the future. As such, investors can't go too far wrong with either stock.</p>\n<p>However, those looking for a value play right now have a solid reason to buy Micron stock, as it is trading&nbsp;at just 20 times trailing earnings. The forward earnings multiple of just 7 makes it even more attractive when compared to AMD, which trades at a multiple of 35. So investors with a higher risk appetite can still go for AMD, as its premium seems justified, while those looking to buy a growth stock on the cheap should take a closer look at Micron Technology.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Buy: AMD vs. Micron Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Buy: AMD vs. Micron Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/17/better-buy-amd-vs-micron-technology/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Five months ago, stock for Advanced Micro Devices (NASDAQ:AMD) and Micron Technology (NASDAQ:MU) were following different trajectories when it came to their prices. Micron started the year on a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/17/better-buy-amd-vs-micron-technology/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司","MU":"美光科技"},"source_url":"https://www.fool.com/investing/2021/09/17/better-buy-amd-vs-micron-technology/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168752097","content_text":"Five months ago, stock for Advanced Micro Devices (NASDAQ:AMD) and Micron Technology (NASDAQ:MU) were following different trajectories when it came to their prices. Micron started the year on a positive note thanks to the terrific demand for memory chips, while AMD was struggling in the wake of the sell-off in tech stocks and market share gains clocked by Intel.\nBut things have changed remarkably for the performance of the two stocks since then.\nAMD data by YCharts\nAMD has regained its mojo thanks to consistently strong quarterly results and a solid outlook for 2021. Micron, on the other hand, has lost investor confidence due to concerns about the health of the memory market. That's not surprising -- investor sentiment in Micron stock is dictated by the booms and busts in the cyclical memory market, as I pointed out in April, while AMD is sitting on secular tailwinds that could ensure long-term growth.\nAs a result, AMD looked like the better buy in April, and the stock's performance since then justifies that call. But with Micron now trading at a dirt-cheap valuation and the prospects of the memory market looking up, is it now a better bet over AMD? Let's find out if my investing advice has changed.\nImage source: Getty Images.\nThe case for Advanced Micro Devices\nThere are three reasons why AMD remains a stock worth buying even after its impressive rally over the past few months.\nFirst, the chipmaker continues to hurt Intel in the x86 CPU (central processing unit) market. Mercury Research estimates that AMD's CPU market share reached a 14-year high in the second quarter of 2021, hitting 22.5%, an increase of 4.2 percentage points over the year-ago quarter. AMD has doubled its CPU market share at Intel's expense in the past two to three years, and it seems on its way to further improve its positioning thanks to an advanced manufacturing process.\nA stronger market share in the CPU space is going to be one of AMD's biggest catalysts, as its computing and graphics business is still quite small compared to Intel's. Similarly, AMD's gains in the server processor market could add billions of dollars to its revenue in the future.\nSecond, AMD is on track to take advantage of growing graphics card demand. Jon Peddie Research estimates that it holds 17% of the discrete graphics processing unit (GPU) market, with Nvidia controlling the rest. There is no doubt that Nvidia is the dominant graphics card provider, but AMD investors shouldn't forget that discrete GPU sales are expected to jump from $29 billion in 2020 to $44 billion in 2023.\nIf AMD continues to hold even a 20% share of the discrete GPU market in the future, it could substantially increase its revenue.\nThird, AMD's dominant position in video gaming consoles adds yet another potent catalyst to the company's portfolio. AMD's enterprise, embedded, and semi-custom (EESC) business is winning big from the Sony PlayStation 5 and the latest Microsoft Xbox consoles, which use its semi-custom chips.\nThe EESC business is built for long-term growth as well, as the new console generation is still in its early phases. According to third-party estimates, the PS5 could clock 67 million units in annual sales by 2024, which would be a huge jump over the 4.5 million units sold last year. Throw in the fact that AMD has won the contract to supply chips for an upcoming handheld gaming console that could turn out to be a big success, and it's easy to see why AMD's EESC business will keep firing on all cylinders.\nGiven all these tailwinds, it is not surprising to see that AMD expects revenue to jump 60% in 2021. Even better, analysts believe that the company's robust growth is here to stay for the long run, as AMD's earnings are expected to grow at an annual pace of over 32% for the next five years. As such, AMD looks all set to sustain its recent rally thanks to multiple growth drivers.\nThe case for Micron\nMicron shares have tumbled over the past few months despite the absence of any visible signs of weakness in the company's business. The company's third-quarter revenue increased 36% year over year to $7.42 billion, while adjusted earnings per share jumped to $1.88 per share from $0.82 per share in the year-ago quarter. The strong memory pricing environment sent Micron's operating income to 31.9% during the quarter from 18% in the year-ago period.\nWhat's more, Micron's guidance suggests that it isn't going to run out of steam. The company expects $8.2 billion in fiscal fourth-quarter revenue and earnings of $2.30 per share, which would translate into 35% year-over-year revenue growth and a sharp jump from the prior-year period's earnings of $1.08 per share. It is surprising to see Micron shares taking a beating despite such outstanding numbers. But investors' trepidation seems justified, as drops in memory prices have historically been bad news for the company.\nHowever, the massive end-market demand for memory chips suggests that memory prices may continue to hold up. For instance, memory industry market research provider TrendForce estimates that robust demand from data center servers could push up server DRAM (dynamic random access memory) prices by 5% to 10% in the current quarter.\nMore importantly, the server market is set up for long-term growth. Mordor Intelligence estimates a 12% annual increase in enterprise server spending through 2026 on account of the deployment of hyperscale data centers and increased server storage demand. A similar scenario is unfolding in the mobile DRAM market, where the deployment of 5G smartphones has led to a sharp increase in demand.\nCounterpoint Research estimates that mobile DRAM revenue increased 30% year over year in the first quarter of 2021 thanks to an increase in the average DRAM capacity per smartphone. As 5G smartphones are being equipped with more DRAM and are still in their early phases of growth, Micron should continue witnessing healthy demand from this market.\nWith mobile and servers accounting for nearly three-fourths of the overall DRAM market, investors' fear of a drop-off in memory demand could remain unjustified. Finally, the secular catalysts Micron stands to gain from could result in a massive acceleration in its revenue and earnings over the coming years, according to analysts' estimates.\nIn fact, analysts expect Micron's earnings to clock a compound annual growth rate of 58% for the next five years, which is substantially higher than what's expected from AMD.\nThe verdict\nBy now it should be evident that both Micron and AMD can continue to sustain their impressive growth in the future. As such, investors can't go too far wrong with either stock.\nHowever, those looking for a value play right now have a solid reason to buy Micron stock, as it is trading at just 20 times trailing earnings. The forward earnings multiple of just 7 makes it even more attractive when compared to AMD, which trades at a multiple of 35. So investors with a higher risk appetite can still go for AMD, as its premium seems justified, while those looking to buy a growth stock on the cheap should take a closer look at Micron Technology.","news_type":1},"isVote":1,"tweetType":1,"viewCount":409,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887273032,"gmtCreate":1632055493226,"gmtModify":1632803108227,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASGLY\">$AGC Inc.(ASGLY)$</a>ssteamed","listText":"<a href=\"https://laohu8.com/S/ASGLY\">$AGC Inc.(ASGLY)$</a>ssteamed","text":"$AGC Inc.(ASGLY)$ssteamed","images":[{"img":"https://static.tigerbbs.com/7722e49926eedbf87a776fc891c38fa1","width":"1080","height":"3826"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887273032","isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":885298697,"gmtCreate":1631794987519,"gmtModify":1631889061306,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575859183800572","authorIdStr":"3575859183800572"},"themes":[],"htmlText":"Steamed","listText":"Steamed","text":"Steamed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885298697","repostId":"1147810356","repostType":4,"isVote":1,"tweetType":1,"viewCount":228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}